These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 33965861)

  • 1. Adamantane derivatives as potential inhibitors of p37 major envelope protein and poxvirus reproduction. Design, synthesis and antiviral activity.
    Shiryaev VA; Skomorohov MY; Leonova MV; Bormotov NI; Serova OA; Shishkina LN; Agafonov AP; Maksyutov RA; Klimochkin YN
    Eur J Med Chem; 2021 Oct; 221():113485. PubMed ID: 33965861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structure-Based Design, Synthesis, and Biological Evaluation of the Cage-Amide Derived Orthopox Virus Replication Inhibitors.
    Mozhaitsev ES; Suslov EV; Rastrepaeva DA; Yarovaya OI; Borisevich SS; Khamitov EM; Kolybalov DS; Arkhipov SG; Bormotov NI; Shishkina LN; Serova OA; Brunilin RV; Vernigora AA; Nawrozkij MB; Agafonov AP; Maksyutov RA; Volcho KP; Salakhutdinov NF
    Viruses; 2022 Dec; 15(1):. PubMed ID: 36680072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vaccinia virus inhibitors as a paradigm for the chemotherapy of poxvirus infections.
    De Clercq E
    Clin Microbiol Rev; 2001 Apr; 14(2):382-97. PubMed ID: 11292644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tick-borne flavivirus reproduction inhibitors based on isoxazole core linked with adamantane.
    Vasilenko DA; Dueva EV; Kozlovskaya LI; Zefirov NA; Grishin YK; Butov GM; Palyulin VA; Kuznetsova TS; Karganova GG; Zefirova ON; Osolodkin DI; Averina EB
    Bioorg Chem; 2019 Jun; 87():629-637. PubMed ID: 30947098
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antiviral activities of two nucleos(t)ide analogs against vaccinia, mpox, and cowpox viruses in primary human fibroblasts.
    Dsouza L; Pant A; Offei S; Priyamvada L; Pope B; Satheshkumar PS; Wang Z; Yang Z
    Antiviral Res; 2023 Aug; 216():105651. PubMed ID: 37270160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An orally bioavailable antipoxvirus compound (ST-246) inhibits extracellular virus formation and protects mice from lethal orthopoxvirus Challenge.
    Yang G; Pevear DC; Davies MH; Collett MS; Bailey T; Rippen S; Barone L; Burns C; Rhodes G; Tohan S; Huggins JW; Baker RO; Buller RL; Touchette E; Waller K; Schriewer J; Neyts J; DeClercq E; Jones K; Hruby D; Jordan R
    J Virol; 2005 Oct; 79(20):13139-49. PubMed ID: 16189015
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substituted adamantylphthalimides: Synthesis, antiviral and antiproliferative activity.
    Mandić L; Benčić P; Mlinarić-Majerski K; Liekens S; Snoeck R; Andrei G; Kralj M; Basarić N
    Arch Pharm (Weinheim); 2020 Jun; 353(6):e2000024. PubMed ID: 32285536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structure-based drug design for envelope protein E2 uncovers a new class of bovine viral diarrhea inhibitors that block virus entry.
    Pascual MJ; Merwaiss F; Leal E; Quintana ME; Capozzo AV; Cavasotto CN; Bollini M; Alvarez DE
    Antiviral Res; 2018 Jan; 149():179-190. PubMed ID: 29031833
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synthesis and anti-viral activity of azolo-adamantanes against influenza A virus.
    Zarubaev VV; Golod EL; Anfimov PM; Shtro AA; Saraev VV; Gavrilov AS; Logvinov AV; Kiselev OI
    Bioorg Med Chem; 2010 Jan; 18(2):839-48. PubMed ID: 20006516
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Synthesis of 1-boraadamantaneamine derivatives with selective astrocyte vs C6 glioma antiproliferative activity. A novel class of anti-hepatitis C agents with potential to bind CD81.
    Wagner CE; Mohler ML; Kang GS; Miller DD; Geisert EE; Chang YA; Fleischer EB; Shea KJ
    J Med Chem; 2003 Jul; 46(14):2823-33. PubMed ID: 12825926
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Machine learning and classical MD simulation to identify inhibitors against the P37 envelope protein of monkeypox virus.
    Rout M; Dey S; Mishra S; Panda S; Singh MK; Sinha R; Dehury B; Pati S
    J Biomol Struct Dyn; 2024 May; 42(8):3935-3948. PubMed ID: 37221882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Design and synthesis of 1,2-annulated adamantane piperidines with anti-influenza virus activity.
    Zoidis G; Kolocouris N; Naesens L; De Clercq E
    Bioorg Med Chem; 2009 Feb; 17(4):1534-41. PubMed ID: 19195900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Bisbenzimide compounds inhibit the replication of prototype and pandemic potential poxviruses.
    Samolej J; Mendonca DC; Upfold N; McElwee M; Landsberger M; Yakimovich A; Patel AH; Strang BL; Mercer J
    Microbiol Spectr; 2024 Apr; 12(4):e0407223. PubMed ID: 38376353
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of wild-type and cidofovir-resistant strains of camelpox, cowpox, monkeypox, and vaccinia viruses.
    Smee DF; Sidwell RW; Kefauver D; Bray M; Huggins JW
    Antimicrob Agents Chemother; 2002 May; 46(5):1329-35. PubMed ID: 11959564
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Symmetric dimeric adamantanes for exploring the structure of two viroporins: influenza virus M2 and hepatitis C virus p7.
    Mandour YM; Breitinger U; Ma C; Wang J; Boeckler FM; Breitinger HG; Zlotos DP
    Drug Des Devel Ther; 2018; 12():1019-1031. PubMed ID: 29750015
    [TBL] [Abstract][Full Text] [Related]  

  • 16. De novo design approaches targeting an envelope protein pocket to identify small molecules against dengue virus.
    Leal ES; Adler NS; Fernández GA; Gebhard LG; Battini L; Aucar MG; Videla M; Monge ME; Hernández de Los Ríos A; Acosta Dávila JA; Morell ML; Cordo SM; García CC; Gamarnik AV; Cavasotto CN; Bollini M
    Eur J Med Chem; 2019 Nov; 182():111628. PubMed ID: 31472473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synthesis and antiviral evaluation of bisnoradamantane sulfites and related compounds.
    Valverde E; Torres E; Guardiola S; Naesens L; Vázquez S
    Med Chem; 2011 Mar; 7(2):135-9. PubMed ID: 21222614
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-influenza activity of diazaadamantanes combined with monoterpene moieties.
    Suslov E; Zarubaev VV; Slita AV; Ponomarev K; Korchagina D; Ayine-Tora DM; Reynisson J; Volcho K; Salakhutdinov N
    Bioorg Med Chem Lett; 2017 Oct; 27(19):4531-4535. PubMed ID: 28886889
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural Immunomodulatory Agents as a Complementary Therapy for Poxviruses.
    Ali SI; Salama A
    Adv Exp Med Biol; 2024; 1451():337-354. PubMed ID: 38801589
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stereoselective synthesis of novel adamantane derivatives with high potency against rimantadine-resistant influenza A virus strains.
    Kuznetsov NY; Tikhov RM; Godovikov IA; Medvedev MG; Lyssenko KA; Burtseva EI; Kirillova ES; Bubnov YN
    Org Biomol Chem; 2017 Apr; 15(15):3152-3157. PubMed ID: 28338150
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.